PRIMAXIN (CILASTATIN SODIUM; IMIPENEM) — FDA Approval ANDA062756 (MERCK)
PRIMAXIN (CILASTATIN SODIUM; IMIPENEM) — FDA Approval ANDA062756 (MERCK) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PRIMAXIN; Active ingredients: CILASTATIN SODIUM; IMIPENEM; Application number: ANDA062756.
| Brand name | PRIMAXIN |
|---|---|
| Active ingredients | CILASTATIN SODIUM; IMIPENEM |
| Application number | ANDA062756 |
| Sponsor | MERCK |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19870108 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →